Methyl 1-benzyl-5-(2-methylpropylamino)-3-(pyridine-3-carbonylamino)pyrrolo[2,3-b]pyridine-2-carboxylate
C26H27N5O3 — CID 26140596
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl 1-benzyl-5-(2-methylpropylamino)-3-(pyridine-3-carbonylamino)pyrrolo[2,3-b]pyridine-2-carboxylate
Methyl 1-benzyl-5-(2-methylpropylamino)-3-(pyridine-3-carbonylamino)pyrrolo[2,3-b]pyridine-2-carboxylate (PubChem CID 26140596) has the molecular formula C26H27N5O3 and a molecular weight of 457.53 g/mol. Its IUPAC name is methyl 1-benzyl-5-(2-methylpropylamino)-3-(pyridine-3-carbonylamino)pyrrolo[2,3-b]pyridine-2-carboxylate.
Molecular Properties
| Compound Name | Methyl 1-benzyl-5-(2-methylpropylamino)-3-(pyridine-3-carbonylamino)pyrrolo[2,3-b]pyridine-2-carboxylate |
|---|---|
| PubChem CID | 26140596 |
| Molecular Formula | C26H27N5O3 |
| Molecular Weight | 457.53 g/mol |
| Exact Mass | 457.21 |
| IUPAC Name | methyl 1-benzyl-5-(2-methylpropylamino)-3-(pyridine-3-carbonylamino)pyrrolo[2,3-b]pyridine-2-carboxylate |
| SMILES | COC(=O)c1c(NC(=O)c2cccnc2)c2cc(NCC(C)C)cnc2n1Cc1ccccc1 |
| InChI | InChI=1S/C26H27N5O3/c1-17(2)13-28-20-12-21-22(30-25(32)19-10-7-11-27-14-19)23(26(33)34-3)31(24(21)29-15-20)16-18-8-5-4-6-9-18/h4-12,14-15,17,28H,13,16H2,1-3H3,(H,30,32) |
| InChIKey | GZMXBWYCCSRJPO-UHFFFAOYSA-N |
| XLogP | 4.59 |
| TPSA | 98.14 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 457.53 |
| LogP ≤ 5 | 4.59 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 26140596 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.